QUOTE AND NEWS
Bloomberg  Jun 25 
 Michael M. Thomas knows his way around wealth, and he’s not impressed by many of the people who have it.
Financial Times  Jun 16 
Germans will be able to sate their appetite for gold after plans were announced to install gold vending machines in airports and railway stations
Bankstocks.com  Jun 15 
Can folks who made millions peddling subprime loans use that same Midas touch to mint money from the housing-market downturn?
Business Wire  Jun 11 
Midas, Inc. (NYSE: MDS), which franchises and operates more than 1,650 Midas automotive service centers in North America, is launching a comprehensive effort aimed at service customers, dealers and employees of automotive dealerships that are
RTTNews  Jun 11 
Thursday, Canadian life sciences company MDS, Inc. (MDZ, MDS.TO) reported a net loss in its second quarter, compared to prior year's profit, primarily hurt by higher one-time expenses, as well as lower revenues. On an adjusted basis, quarterly...
Market Wire  Jun 10 
NEW YORK, NY -- (Marketwire) -- 06/10/09 -- The Midas Funds (NASDAQ: MIDSX) (NASDAQ: MPERX) (NASDAQ: MISEX) will be paying the following distributions which are scheduled with a record date of June 26, 2009 and an ex-dividend, reinvestment, and
Wall Street Journal  Jun 5 
The shutdown of a Canadian nuclear reactor that is a crucial supplier of medical scanning isotopes is interrupting care to patients and hindering suppliers.
Market Wire  Jun 3 
LOS ANGELES, CA -- (Marketwire) -- 06/03/09 -- Rarely does a novel transcend bookstore shelves and rise to a pop culture phenomenon, becoming a franchise right out of the gates. "THE SEVEN SINS: The Tyrant Ascending" is that rare novel. Once you read
FierceBiotech  Jun 1 
Canada's MDS has sold off its Phase II-IV clinical development ops to INC Research for $50 million. And with the focus at MDS shifting to early-stage research, executives say they have also put their central labs operation on the market. INC's...
Reuters  Jun 1 
MDS Inc said on Monday that it planned to narrow its contract research focus by selling its late stage operations and central laboratory divisions.
FiercePharma  Jun 1 
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
BULLS: REASONS TO BUY
Bulls: Reasons To Buy
Feeling Bullish? Be the first to explain why this would make a good investment
See All (0)
BEARS: REASONS TO SELL
Bears: Reasons To Sell
Feeling Bearish? Be the first to explain why this would make a poor investment
See All (0)


 
MDS AT A GLANCE
 
 
 
 
 
 
 
 
Please install Flash Player to view this chart.



[edit] References

 
Worried about pump and dump?
We review changes
for stock spam
Want to make Wikinvest better?
We need your help,
contribute today
Do you write software?
We are recruiting
the best engineers
Like Wikinvest?
Spread the word —
Tell your friends!
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki